Dec. 28, 2022

A Brief Chat with Amir London, CEO of Kamada

A Brief Chat with Amir London, CEO of Kamada
Spotify podcast player badge
Apple Podcasts podcast player badge
Pandora podcast player badge
RSS Feed podcast player badge
Spotify podcast player icon Apple Podcasts podcast player icon Pandora podcast player icon RSS Feed podcast player icon

In this 13-minute chat, Amir London, CEO of Kamada (NASDAQ: KMDA), discusses its proprietary platform technology with potential to treat Alpha-1 Antitrypsin Deficiency patients.